Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer

This publication has 34 references indexed in Scilit:

• Inhibition of Ephrin B3-mediated survival signaling contributes to increased cell death response of non-small cell lung carcinoma cells after combined treatment with ionizing radiation and PKC 412
  Cell Death & Disease, 2013
• A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo
  PLOS ONE, 2012
• Role of Adjuvant Chemotherapy in NSCLC (Stages I to III)
  Surgical Oncology Clinics of North America, 2011
• Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells
  Cellular Signalling, 2011
• Eph receptors and ephrins in cancer: bidirectional signalling and beyond
  Nature Reviews Cancer, 2010
• EphA2 Mediates Ligand-Dependent Inhibition and Ligand-Independent Promotion of Cell Migration and Invasion via a Reciprocal Regulatory Loop with Akt
  Cancer Cell, 2009
• EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
• Somatic mutations affect key pathways in lung adenocarcinoma
  Nature, 2008
• Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application
  Biochemical and Biophysical Research Communications, 2004
• ESTABLISHMENT AND CHARACTERIZATION OF CELL LINES FROM HUMAN SMALL CELL AND LARGE CELL CARCINOMAS OF THE LUNG
  Acta Pathologica Microbiologica Scandinavica Series A :Pathology, 1985